GT-TNF alpha-mAb 004

N/A

Report date: 2025/03/20 15:23:50

Base Information

Drug NameGT-TNF alpha-mAb 004
Drug Alias NameTNF alpha mAb (Geneaty Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeneaty Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGeneaty Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A